等待开盘 07-08 09:30:00 美东时间
+1.470
+2.91%
今日重点评级关注:摩根大通:上调Camp4 Therapeutics评级至"超配",目标价从5美元升至9美元;Canaccord Genuity:维持Rhythm制药"买入"评级,目标价从143美元升至151美元
06-17 11:32
Stifel analyst Stephen Gengaro reiterates Cactus (NYSE:WHD) with a Buy and raises the price target from $66 to $68.
06-16 23:21
华盛资讯6月3日讯,Cactus, Inc. Class A公布2025财年年度业绩,公司年度营收10.79亿美元,同比下降4.5%,归母净利润2.02亿美元,同比下滑13.4%。
06-03 06:33
今日重点评级关注:Oppenheimer:维持Protara Therapeutics"跑赢大市"评级,目标价从25美元升至28美元;Piper Sandler:维持Bright Minds Biosciences"超配"评级,目标价从190美元升至220美元
05-21 12:05
今日重点评级关注:TD Cowen:维持Strive"买入"评级,目标价从28美元升至30美元;蒙特利尔银行:维持KinderCare Learning"跑赢大市"评级,目标价从4美元升至6美元
05-19 10:55
Piper Sandler analyst Derek Podhaizer maintains Cactus (NYSE:WHD) with a Overweight and raises the price target from $69 to $72.
05-18 22:47
今日重点评级关注:HC Wainwright & Co.:维持Caribou Biosciences"买入"评级,目标价从9美元升至11美元;康托·菲茨杰拉德:维持Artiva Biotherapeutics"超配"评级,目标价从10美元升至40美元
05-12 12:36
Barclays analyst David Anderson maintains Cactus (NYSE:WHD) with a Overweight and raises the price target from $62 to $70.
05-11 21:18
华盛资讯5月7日讯,Cactus, Inc. Class A公布2026财年Q1业绩,公司Q1营收3.88亿美元,同比增长38.6%,归母净利润亏损0.49亿美元,由盈转亏。
05-07 21:58
Cactus (NYSE:WHD) reported quarterly earnings of $0.70 per share which beat the analyst consensus estimate of $0.64 by 9.37 percent. This is a 4.11 percent decrease over earnings of $0.73 per share from the same period
05-07 14:11